Federal Register / Vol. 86, No. 14 / Monday, January 25, 2021 / Notices 6919 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Katherine Hiner, Office of Docket 

Services, U.S. International Trade 

Commission, telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2020). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

January 19, 2021, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 

1–3, 6, 7, 9, 14, 17, 18, 20, and 21 of the 

’665 patent; and claims 1, 2, 7, 8, 11, 12, 

19, 20, 26, and 27 of the ’345 patent; and 

whether an industry in the United 

States exists as required by subsection 

(a)(2) of section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘gabapentin 

immunoassays kits, gabapentin-specific 

test strips, multi-drug test kits and strips 

that test for gabapentin among other 

drugs, and components of such kits and 

test strips’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainant is: 

ARK Diagnostics, Inc., 48089 Fremont 

Boulevard, Fremont, CA 94538. 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

Hangzhou AllTest Biotech Co., Ltd., No. 

550, Yinhai Street, Hangzhou 

Economy and Technology 

Development Area, Hangzhou, China 

210018. 

Shanghai Chemtron Biotech Co., Ltd., 

No. 518, Qingdai Rd., International 

Medical Park, Pudong 201318, 

Shanghai, China. 

Chemtron Biotech Co., Ltd., 9425 Brown 

Deer Road, Suite B, San Diego, CA 

92121. 

Zhejiang Orient Gene Biotech Co., Ltd., 

#3787 East Yangguang Ave., Dipu St., 

Anji 313300, Huzhou, Zhejiang, 

China. 

Healgen Scientific, LLC, 3818 Fuqua 

Street, Houston, TX 77047. 

Kappa City Biotech, SAS, 32 Rue 

Danton, 03100 Montlucon, France. 

12PanelMedical, Inc., 846 Wee Burn 

Street, Apt. E306, Sarasota, FL 34243. 

Acro Biotech, Inc., 9500 7th Street, Unit 

M, Rancho Cucamonga, CA 91730. 

AlcoPro, Inc., 2547 Sutherland Ave., 

Knoxville, TN 37919. 

American Screening, LLC, 9742 St. 

Vincent Ave., Ste. 100, Shreveport, 

LA 71106. 

Confirm Biosciences, Inc., 10123 Carroll 

Canyon Road, San Diego, CA 92131. 

Mercedes Medical, LLC, 12210 

Rangeland Parkway, Lakewood 

Ranch, FL 34211. 

TransMed Co., LLC, 1887 McFarland 

Parkway, Alpharetta, GA 30005. 

Transmetron, Inc., 1476 S Major Street 

(50 East), Salt Lake City, UT 84115. 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party in this investigation. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainant of the 

complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: January 19, 2021. 

William Bishop, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2021–01548 Filed 1–22–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On January 14, 2021, the Department 

of Justice lodged a proposed consent 

decree with the United States District 

Court for the Middle District of North 

Carolina in United States v. Pilkington 

North America, Inc., Civil Action No. 

1:21–cv–00040. 

The United States filed a complaint 

under Clean Air Act (CAA) Sections 

113(b) and 167, 42 U.S.C. 7413(b) and 

7477, seeking injunctive relief for the 

Defendant’s alleged failure to (1) obtain 

appropriate permits before modifying 

and subsequently operating Furnace No. 

1 at its glass manufacturing facility in 

Laurinburg, North Carolina, and (2) 

install and employ the best available 

control technology (BACT) to control 

emissions of nitrogen oxides (NOX), 

sulfur dioxide (SO2), and particulate 

matter (PM) from Furnace No. 1, as 

required by the CAA. The United States 

simultaneously lodged a consent decree 

that would settle the claims in the 

complaint. 

Under the proposed decree, the 

Defendant will have to (1) install 

equipment on Furnace No. 1 to control 

emissions of NOX, SO2, and PM from 

the furnace; (2) install equipment on 

Furnace No. 1 to continuously monitor 

NOX and SO2 emissions from the 

furnace and perform annual stack tests 

to monitor PM emissions from the 

furnace; (3) meet interim and final 

limits for emissions of NOX, SO2, and 

PM from Furnace No. 1; (4) incorporate 

certain requirements of the decree into 

a permit; and (5) perform a project to 

mitigate excess PM emissions from the 

Laurinburg facility. 

The publication of this notice opens 

a period for public comment on the 

proposed consent decree. Comments 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division, and should 

refer to United States v. Pilkington 

North America, Inc., D.J. Ref. No. 90–5– 

2–1–10328. All comments must be 


jbell on DSKJLSW7X2PROD with NOTICES
6920 Federal Register / Vol. 86, No. 14 / Monday, January 25, 2021 / Notices 

submitted no later than thirty (30) days 

after the publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the proposed consent decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

proposed consent decree upon written 

request and payment of reproduction 

costs. Please mail your request and 

payment to: Consent Decree Library, 

U.S. DOJ—ENRD, P.O. Box 7611, 

Washington, DC 20044–7611. 

Please enclose a check or money order 

for $21.25 (25 cents per page 

reproduction cost) payable to the United 

States Treasury. 

Lori Jonas, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2021–01436 Filed 1–22–21; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act 

On January 15, 2021, the Department 

of Justice and the State of California on 

behalf of the California Department of 

Toxic Substances Control (‘‘DTSC’’) 

lodged a proposed Consent Decree with 

the United States District Court for the 

Central District of California pertaining 

to environmental contamination at the 

Dense Non-Aqueous Phase Liquid 

Operable Unit (‘‘DNAPL OU’’) of the 

Montrose Chemical Corp. Superfund 

Site in Los Angeles County, California. 

This proposed Consent Decree was 

lodged in the case United States of 

America and State of California vs. 

Montrose Chemical Corp. of California 

et al., Civil Action No. 2:90–cv–03122 

DOC (C.D. Cal.); it resolves certain of the 

claims in that case. 

The proposed Consent Decree, titled 

in full ‘‘Partial Consent Decree 

(Montrose Superfund Site—Dense NonAqueous Phase Liquid (DNAPL) 

Operable Unit)’’, resolves certain claims 

or potential claims under Sections 106 

and 107 of the Comprehensive 

Environmental Response, 

Compensation, and Liability Act, 42 

U.S.C. 9606, 9607, as well as certain 

potential state law claims, in connection 

with environmental contamination at 

the DNAPL OU. The settling defendants 

are TFCF America, Inc.; Bayer 

CropScience Inc.; Montrose Chemical 

Corporation of California; and Stauffer 

Management Company LLC. The 

Consent Decree requires the settling 

defendants to perform the remedy at the 

DNAPL OU, which consists primarily of 

in-situ thermal treatment (electrical 

resistance heating) and soil vapor 

extraction with an associated land use 

covenant, and to make a payment of 

$340,000.00 toward the United States’ 

unreimbursed DNAPL OU past costs 

and a payment of $61,798.11 towards 

DTSC’s DNAPL OU past costs. The 

proposed Consent Decree also requires 

the settling defendants to pay the 

United States’ and DTSC’s future 

response costs for overseeing the work 

the settling defendants will be 

performing at the DNAPL OU. 

The publication of this notice opens 

a period for public comment on the 

Consent Decree. Comments should be 

addressed to the Assistant Attorney 

General, Environment and Natural 

Resources Division, and should refer to 

United States of America and State of 

California vs. Montrose Chemical Corp. 

of California et al, D.J. Ref. No. 90–11– 

3–511. All comments must be submitted 

no later than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the Consent Decree may be examined 

and downloaded at this Justice 

Department website: https://

www.usdoj.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

Consent Decree upon written request 

and payment of reproduction costs. 

Please mail your request and payment 

to: Consent Decree Library, U.S. DOJ— 

ENRD, P.O. Box 7611, Washington, DC 

20044–7611. 

Please enclose a check or money order 

for $133.00 (25 cents per page 

reproduction cost) for the Consent 

Decree, payable to the United States 

Treasury. For a paper copy without the 

appendices and signature pages, the cost 

is $21.50. 

Lori Jonas, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2021–01549 Filed 1–22–21; 8:45 am] 

BILLING CODE 4410–15–P 

NATIONAL ARCHIVES AND RECORDS 

ADMINISTRATION 

[NARA–21–0001; NARA–2021–012] 

Records Schedules; Availability and 

Request for Comments 

AGENCY: National Archives and Records 

Administration (NARA). 

ACTION: Notice of availability of 

proposed records schedules; request for 

comments. 

SUMMARY: The National Archives and 

Records Administration (NARA) 

publishes notice of certain Federal 

agency requests for records disposition 

authority (records schedules). We 

publish notice in the Federal Register 

and on regulations.gov for records 

schedules in which agencies propose to 

dispose of records they no longer need 

to conduct agency business. We invite 

public comments on such records 

schedules. 

DATES: NARA must receive comments 

by March 11, 2021. 

ADDRESSES: You may submit comments 

by either of the following methods. You 

must cite the control number, which 

appears on the records schedule in 

parentheses after the name of the agency 

that submitted the schedule. 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. 

• Mail: Records Appraisal and 

Agency Assistance (ACR); National 

Archives and Records Administration; 

8601 Adelphi Road; College Park, MD 

20740–6001. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly Keravuori, Regulatory and 

External Policy Program Manager, by 

email at regulation_comments@

nara.gov. For information about records 

schedules, contact Records Management 

Operations by email at 

request.schedule@nara.gov, by mail at 

the address above, or by phone at 301– 

837–1799. 

SUPPLEMENTARY INFORMATION: 

Public Comment Procedures 

We are publishing notice of records 

schedules in which agencies propose to 


jbell on DSKJLSW7X2PROD with NOTICES